Cargando…
CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection
OBJECTIVE: To explore changes in CSF sTREM2 concentrations in the evolving course of HIV-1 infection. METHODS: In this retrospective cross-sectional study, we measured concentrations of the macrophage/microglial activation marker sTREM2 in CSF samples from 121 HIV-1–infected adults and 11 HIV-negati...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278890/ https://www.ncbi.nlm.nih.gov/pubmed/30568991 http://dx.doi.org/10.1212/NXI.0000000000000512 |
_version_ | 1783378448629104640 |
---|---|
author | Gisslén, Magnus Heslegrave, Amanda Veleva, Elena Yilmaz, Aylin Andersson, Lars-Magnus Hagberg, Lars Spudich, Serena Fuchs, Dietmar Price, Richard W. Zetterberg, Henrik |
author_facet | Gisslén, Magnus Heslegrave, Amanda Veleva, Elena Yilmaz, Aylin Andersson, Lars-Magnus Hagberg, Lars Spudich, Serena Fuchs, Dietmar Price, Richard W. Zetterberg, Henrik |
author_sort | Gisslén, Magnus |
collection | PubMed |
description | OBJECTIVE: To explore changes in CSF sTREM2 concentrations in the evolving course of HIV-1 infection. METHODS: In this retrospective cross-sectional study, we measured concentrations of the macrophage/microglial activation marker sTREM2 in CSF samples from 121 HIV-1–infected adults and 11 HIV-negative controls and examined their correlations with other CSF and blood biomarkers of infection, inflammation, and neuronal injury. RESULTS: CSF sTREM2 increased with systemic and CNS HIV-1 disease severity, with the highest levels found in patients with HIV-associated dementia (HAD). In untreated HIV-1–infected patients without an HAD diagnosis, levels of CSF sTREM2 increased with decreasing CD4(+) T-cell counts. CSF concentrations of both sTREM2 and the neuronal injury marker neurofilament light protein (NFL) were significantly associated with age. CSF sTREM2 levels were also independently correlated with CSF NFL. Notably, this association was also observed in HIV-negative controls with normal CSF NFL. HIV-infected patients on suppressive antiretroviral treatment had CSF sTREM2 levels comparable to healthy controls. CONCLUSIONS: Elevations in CSF sTREM2 levels, an indicator of macrophage/microglial activation, are a common feature of untreated HIV-1 infection that increases with CD4(+) T-cell loss and reaches highest levels in HAD. The strong and independent association between CSF sTREM2 and CSF NFL suggests a linkage between microglial activation and neuronal injury in HIV-1 infection. CSF sTREM2 has the potential of being a useful biomarker of innate CNS immune activation in different stages of untreated and treated HIV-1 infection. |
format | Online Article Text |
id | pubmed-6278890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-62788902018-12-19 CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection Gisslén, Magnus Heslegrave, Amanda Veleva, Elena Yilmaz, Aylin Andersson, Lars-Magnus Hagberg, Lars Spudich, Serena Fuchs, Dietmar Price, Richard W. Zetterberg, Henrik Neurol Neuroimmunol Neuroinflamm Article OBJECTIVE: To explore changes in CSF sTREM2 concentrations in the evolving course of HIV-1 infection. METHODS: In this retrospective cross-sectional study, we measured concentrations of the macrophage/microglial activation marker sTREM2 in CSF samples from 121 HIV-1–infected adults and 11 HIV-negative controls and examined their correlations with other CSF and blood biomarkers of infection, inflammation, and neuronal injury. RESULTS: CSF sTREM2 increased with systemic and CNS HIV-1 disease severity, with the highest levels found in patients with HIV-associated dementia (HAD). In untreated HIV-1–infected patients without an HAD diagnosis, levels of CSF sTREM2 increased with decreasing CD4(+) T-cell counts. CSF concentrations of both sTREM2 and the neuronal injury marker neurofilament light protein (NFL) were significantly associated with age. CSF sTREM2 levels were also independently correlated with CSF NFL. Notably, this association was also observed in HIV-negative controls with normal CSF NFL. HIV-infected patients on suppressive antiretroviral treatment had CSF sTREM2 levels comparable to healthy controls. CONCLUSIONS: Elevations in CSF sTREM2 levels, an indicator of macrophage/microglial activation, are a common feature of untreated HIV-1 infection that increases with CD4(+) T-cell loss and reaches highest levels in HAD. The strong and independent association between CSF sTREM2 and CSF NFL suggests a linkage between microglial activation and neuronal injury in HIV-1 infection. CSF sTREM2 has the potential of being a useful biomarker of innate CNS immune activation in different stages of untreated and treated HIV-1 infection. Lippincott Williams & Wilkins 2018-11-07 /pmc/articles/PMC6278890/ /pubmed/30568991 http://dx.doi.org/10.1212/NXI.0000000000000512 Text en Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Article Gisslén, Magnus Heslegrave, Amanda Veleva, Elena Yilmaz, Aylin Andersson, Lars-Magnus Hagberg, Lars Spudich, Serena Fuchs, Dietmar Price, Richard W. Zetterberg, Henrik CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection |
title | CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection |
title_full | CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection |
title_fullStr | CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection |
title_full_unstemmed | CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection |
title_short | CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection |
title_sort | csf concentrations of soluble trem2 as a marker of microglial activation in hiv-1 infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278890/ https://www.ncbi.nlm.nih.gov/pubmed/30568991 http://dx.doi.org/10.1212/NXI.0000000000000512 |
work_keys_str_mv | AT gisslenmagnus csfconcentrationsofsolubletrem2asamarkerofmicroglialactivationinhiv1infection AT heslegraveamanda csfconcentrationsofsolubletrem2asamarkerofmicroglialactivationinhiv1infection AT velevaelena csfconcentrationsofsolubletrem2asamarkerofmicroglialactivationinhiv1infection AT yilmazaylin csfconcentrationsofsolubletrem2asamarkerofmicroglialactivationinhiv1infection AT anderssonlarsmagnus csfconcentrationsofsolubletrem2asamarkerofmicroglialactivationinhiv1infection AT hagberglars csfconcentrationsofsolubletrem2asamarkerofmicroglialactivationinhiv1infection AT spudichserena csfconcentrationsofsolubletrem2asamarkerofmicroglialactivationinhiv1infection AT fuchsdietmar csfconcentrationsofsolubletrem2asamarkerofmicroglialactivationinhiv1infection AT pricerichardw csfconcentrationsofsolubletrem2asamarkerofmicroglialactivationinhiv1infection AT zetterberghenrik csfconcentrationsofsolubletrem2asamarkerofmicroglialactivationinhiv1infection |